TP53 and cancer: P53 mutations and lack of p21-mediated cell arrest have been suggested to render cancer cells resistant to temozolomide (Tentori et al, 1998; Hirose et al, 2001; Bocangel et al, 2002), although the data on the implication of p53 in temozolomide resistance are not consistent (Middlemas et al, 2000).